Concepedia

Philipp Holzer

PH

Statistics

Publications

23

Citations

1.7K

H-Index

19

Active since

2000

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (China)

Novartis (United States)

Peptidream (Japan)

Philipp Holzer is an author at Novartis (Switzerland) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2000–2024

23

Publications

23

Click chemistry in materials synthesis. 1. Adhesive polymers from copper‐catalyzed azide‐alkyne cycloaddition

David Díaz Díaz, Sreenivas Punna, Philipp Holzer et al. · Journal of Polymer Science Part A Polymer Chemistry · 2004 · 419 citations

, , +17

Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors

Philipp Holzer, Keiichi Masuya, Pascal Furet et al. · Journal of Medicinal Chemistry · 2015 · 206 citations · Full text

, , +15

The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis

Georg Martiny‐Baron, Philipp Holzer, Éric Billy et al. · Angiogenesis · 2010 · 126 citations · Full text

, , +16

A Supramolecular Enzyme Mimic That Catalyzes the 15,15′ Double Bond Scission of ,-Carotene

Richard R. French, Philipp Holzer, Michele Leuenberger et al. · Angewandte Chemie International Edition · 2000 · 103 citations · Full text

, , +16

DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

Martin Schröder, Martin Renatus, Xiaoyou Liang et al. · Nature Communications · 2024 · 88 citations · Full text

, , +13

1–5 of 23